These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31532766)

  • 1. The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.
    Binquet C; Lejeune C; Seror V; Peyron F; Bertaux AC; Scemama O; Quantin C; Béjean S; Stillwaggon E; Wallon M
    PLoS One; 2019; 14(9):e0221709. PubMed ID: 31532766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of congenital toxoplasmosis in France. Risk assessment. Results and perspectives of prenatal screening and newborn follow up].
    Ambroise-Thomas P; Schweitzer M; Pinon JM; Thiebaugeorges O
    Bull Acad Natl Med; 2001; 185(4):665-83; discussion 684-8. PubMed ID: 11503357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of prevention strategies for congenital toxoplasmosis: a critical review of medico-economic studies].
    Binquet C; Wallon M; Quantin C; Gadreau M; Peyron F
    Rev Epidemiol Sante Publique; 2002 Oct; 50(5):475-87. PubMed ID: 12471340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving.
    Prusa AR; Kasper DC; Sawers L; Walter E; Hayde M; Stillwaggon E
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005648. PubMed ID: 28692640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients' data.
    ; Thiébaut R; Leproust S; Chêne G; Gilbert R
    Lancet; 2007 Jan; 369(9556):115-22. PubMed ID: 17223474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of congenital toxoplasmosis in France using prenatal screening: A decision-analytic economic model.
    Sawers L; Wallon M; Mandelbrot L; Villena I; Stillwaggon E; Kieffer F
    PLoS One; 2022; 17(11):e0273781. PubMed ID: 36331943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
    Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
    Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-benefit analysis of screening for congenital toxoplasmosis].
    Sagmeister M; Gessner U; Kind C; Horisberger B
    Schweiz Med Wochenschr Suppl; 1995; 65():103S-112S. PubMed ID: 7716447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prenatal screening of congenital toxoplasmosis].
    Ortega-Benito JM
    Med Clin (Barc); 2001 Mar; 116(10):385-9. PubMed ID: 11333674
    [No Abstract]   [Full Text] [Related]  

  • 10. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
    Paquet C; Yudin MH;
    J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal screening for toxoplasmosis.
    Bader TJ; Macones GA; Asch DA
    Obstet Gynecol; 1997 Sep; 90(3):457-64. PubMed ID: 9277662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal treatment for serious neurological sequelae of congenital toxoplasmosis: an observational prospective cohort study.
    Cortina-Borja M; Tan HK; Wallon M; Paul M; Prusa A; Buffolano W; Malm G; Salt A; Freeman K; Petersen E; Gilbert RE;
    PLoS Med; 2010 Oct; 7(10):. PubMed ID: 20967235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.
    Stillwaggon E; Carrier CS; Sautter M; McLeod R
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1333. PubMed ID: 21980546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery.
    Lago EG; Neto EC; Melamed J; Rucks AP; Presotto C; Coelho JC; Parise C; Vargas PR; Goldbeck AS; Fiori RM
    Paediatr Perinat Epidemiol; 2007 Nov; 21(6):525-31. PubMed ID: 17937738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxoplasmosis in pregnancy in an area with low seroprevalence: is prenatal screening still worthwhile?
    Capretti MG; De Angelis M; Tridapalli E; Orlandi A; Marangoni A; Moroni A; Guerra B; Arcuri S; Marsico C; Faldella G
    Pediatr Infect Dis J; 2014 Jan; 33(1):5-10. PubMed ID: 24064557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serological prenatal screening to detect Toxoplasma gondii infections in Austria.
    Prusa AR; Kasper DC; Olischar M; Husslein P; Pollak A; Hayde M
    Neonatology; 2013; 103(1):27-34. PubMed ID: 23018152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group .
    Lebech M; Andersen O; Christensen NC; Hertel J; Nielsen HE; Peitersen B; Rechnitzer C; Larsen SO; Nørgaard-Pedersen B; Petersen E
    Lancet; 1999 May; 353(9167):1834-7. PubMed ID: 10359408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of congenital toxoplasmosis in France: current data].
    Garcia-Méric P; Franck J; Dumon H; Piarroux R
    Presse Med; 2010 May; 39(5):530-8. PubMed ID: 19926248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital toxoplasmosis: is screening desirable?
    Foulon W
    Scand J Infect Dis Suppl; 1992; 84():11-7. PubMed ID: 1290068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of congenital toxoplasmosis in Slovenia by serological screening of pregnant women.
    Logar J; Petrovec M; Novak-Antolic Z; Premru-Srsen T; Cizman M; Arnez M; Kraut A
    Scand J Infect Dis; 2002; 34(3):201-4. PubMed ID: 12030394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.